May 23, 2019
FDA grants Stryker premarket approval for intracranial aneurysm stent
Editor's Note
Stryker announced on May 20 that the Food & Drug Administration (FDA) granted premarket approval for its Neuroform Atlas stent system for intracranial aneurysms, the May 20 MassDevice reports.
The self-expanding nitinol stent can now be used with neurovascular embolization coils to treat patients with saccular wide-necked intracranial aneurysms that arise from a 2 mm to 4.5 mm parent vessel.
Free Daily News
- Study: Mechanical heart valves outperform biological for long-term survival in middle-aged patients
- Study: Virtual reality reduces preoperative anxiety in heart surgery patients
- CABG, TAVR drive hospital revenue despite cost variations
- Rural hospital closures drive up surgical travel times and costs
- Human trafficking in healthcare supply chains often underrecognized, expert argues
- Session: Anchors Away: 5 Strategies to Right-Size Your Inventory and Improve Supply Contracts
- Closing Keynote: Trimming the Sails: Improving Perioperative Efficiency by Managing Same-Day Admission Transitions
- Session: Navigating the Storm: Ensuring Operational Continuity Through Crisis Leadership
- Session: Cracking the Code: Innovative Hacks for Preference Card Management and C-Suite Support
- Session: Crew Incentives: 3 Guiding Principles to Leverage Value Analysis Teams
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement